Format

Send to

Choose Destination
Clin Infect Dis. 2010 Nov 1;51(9):1070-2. doi: 10.1086/656585.

A 4‐site, single‐visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: experiences with >5000 patients.

Author information

1
Queen Saovabha Memorial Institute, Thai Red Cross Society, World Health Organization Collaborating Center for Research in Rabies Pathogenesis and Treatment, Bangkok, Thailand. sprapimporn@gmail.com

Abstract

We previously demonstrated that 4‐site, intradermal, single‐visit rabies booster vaccination provides immunogenicity greater than that provided by the standard 2‐booster, 2‐visit regimen. The regimen has been routinely used in 5116 patients since 1998 without any treatment failure. It is not only effective but also saves vaccine costs and transportation expenses and improves compliance.

PMID:
20887204
DOI:
10.1086/656585
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center